Klionsky Yael, Antonelli Maria
Case Western Reserve University at MetroHealth Medical Center, Cleveland, Ohio.
ACR Open Rheumatol. 2020 Feb;2(2):74-78. doi: 10.1002/acr2.11105. Epub 2020 Jan 6.
In the following review, we seek to provide an overview of the current understanding of various thyroid manifestations affecting patients with systemic lupus erythematosus (SLE), including topics ranging from thyroid-related complications to SLE in pregnancy. Autoimmune diseases tend to coincide, and an association between thyroid disease and SLE has been reported for more than 50 years. There is no evidence that the coexistence of thyroid disease and lupus alters the disease course or manifestations of either. Both hypothyroidism and thyroid nodules are seen more frequently in patients with SLE than in the general population. The rate of thyroid cancer is twice as prevalent in patients with SLE compared with those without SLE. Several forms of thyroid disease are more common among patients with SLE, with adverse consequences in pregnancy. Future work will require delineating the mechanism behind these associations and understanding the role of antirheumatic agents with concomitant thyroid disease.
在以下综述中,我们旨在概述目前对系统性红斑狼疮(SLE)患者各种甲状腺表现的认识,包括从甲状腺相关并发症到妊娠期SLE等主题。自身免疫性疾病往往同时存在,甲状腺疾病与SLE之间的关联已有50多年的报道。没有证据表明甲状腺疾病与狼疮并存会改变任何一方的疾病进程或表现。与普通人群相比,SLE患者中甲状腺功能减退和甲状腺结节更为常见。SLE患者的甲状腺癌发生率是无SLE患者的两倍。几种甲状腺疾病在SLE患者中更为常见,在妊娠期会产生不良后果。未来的工作需要阐明这些关联背后的机制,并了解抗风湿药物在合并甲状腺疾病时的作用。